Next Article in Journal
Morpholino Analogues of Fingolimod as Novel and Selective S1P1 Ligands with In Vivo Efficacy in a Mouse Model of Experimental Antigen-Induced Encephalomyelitis
Next Article in Special Issue
Cardiac Protective Effect of Kirenol against Doxorubicin-Induced Cardiac Hypertrophy in H9c2 Cells through Nrf2 Signaling via PI3K/AKT Pathways
Previous Article in Journal
Methods Favoring Homology-Directed Repair Choice in Response to CRISPR/Cas9 Induced-Double Strand Breaks
Previous Article in Special Issue
Cardiac-Specific Overexpression of Catalytically Inactive Corin Reduces Edema, Contractile Dysfunction, and Death in Mice with Dilated Cardiomyopathy

Molecular Basis of Inflammation in the Pathogenesis of Cardiomyopathies

Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, 80131 Naples, Italy
Dipartimento di Medicina Molecolaree Biotecnologie Mediche, University of Naples “Federico II”, 80138 Naples, Italy
CEINGE-Biotecnologie Avanzate Scarl, Via G. Salvatore 486, 80138 Naples, Italy
Task Force sugli Studi del Microbioma, University of Naples “Federico II”, 80138 Naples, Italy
Institute of Cardiovascular Sciences, University College of London and St. Bartholomew’s Hospital, London WC1E 6DD, UK
Author to whom correspondence should be addressed.
Member of ERN GUARD-HEART (European Reference Network for Rare and Complex Diseases of the Heart).
Int. J. Mol. Sci. 2020, 21(18), 6462;
Received: 7 August 2020 / Revised: 25 August 2020 / Accepted: 2 September 2020 / Published: 4 September 2020
(This article belongs to the Special Issue Biomolecular Mediators in Cardiomyopathies)
Cardiomyopathies (CMPs) represent a diverse group of heart muscle diseases, grouped into specific morphological and functional phenotypes. CMPs are associated with mutations in sarcomeric and non-sarcomeric genes, with several suspected epigenetic and environmental mechanisms involved in determining penetrance and expressivity. The understanding of the underlying molecular mechanisms of myocardial diseases is fundamental to achieving a proper management and treatment of these disorders. Among these, inflammation seems to play an important role in the pathogenesis of CMPs. The aim of the present study is to review the current knowledge on the role of inflammation and the immune system activation in the pathogenesis of CMPs and to identify potential molecular targets for a tailored anti-inflammatory treatment. View Full-Text
Keywords: inflammation; cardiomyopathies; pathogenesis inflammation; cardiomyopathies; pathogenesis
Show Figures

Figure 1

MDPI and ACS Style

Monda, E.; Palmiero, G.; Rubino, M.; Verrillo, F.; Amodio, F.; Di Fraia, F.; Pacileo, R.; Fimiani, F.; Esposito, A.; Cirillo, A.; Fusco, A.; Moscarella, E.; Frisso, G.; Russo, M.G.; Pacileo, G.; Calabrò, P.; Scudiero, O.; Caiazza, M.; Limongelli, G. Molecular Basis of Inflammation in the Pathogenesis of Cardiomyopathies. Int. J. Mol. Sci. 2020, 21, 6462.

AMA Style

Monda E, Palmiero G, Rubino M, Verrillo F, Amodio F, Di Fraia F, Pacileo R, Fimiani F, Esposito A, Cirillo A, Fusco A, Moscarella E, Frisso G, Russo MG, Pacileo G, Calabrò P, Scudiero O, Caiazza M, Limongelli G. Molecular Basis of Inflammation in the Pathogenesis of Cardiomyopathies. International Journal of Molecular Sciences. 2020; 21(18):6462.

Chicago/Turabian Style

Monda, Emanuele, Giuseppe Palmiero, Marta Rubino, Federica Verrillo, Federica Amodio, Francesco Di Fraia, Roberta Pacileo, Fabio Fimiani, Augusto Esposito, Annapaola Cirillo, Adelaide Fusco, Elisabetta Moscarella, Giulia Frisso, Maria G. Russo, Giuseppe Pacileo, Paolo Calabrò, Olga Scudiero, Martina Caiazza, and Giuseppe Limongelli. 2020. "Molecular Basis of Inflammation in the Pathogenesis of Cardiomyopathies" International Journal of Molecular Sciences 21, no. 18: 6462.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop